Zaid Kasmikha, DO
Cardiovascular Disease · Saint Clair Shores, MINPI 1083902761
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,976 of the $16,298 with a category attached, or 61.2%. It is spread thinly across 33 manufacturers, the largest accounting for just 22.1%. Reporting peaked in 2024 at $5,184 and has fallen 52.1% since, to $2,485 in 2025.
Across 209 payments — averaging $77.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- Penumbra, Inc.$2K
- Boston Scientific$2K
- Medtronic$1K
- Inari Medical, Inc.$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$762
- plus $5K from 27 others
Across 5 payments — averaging $346.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Inari Medical, Inc.$2K
What the payments were for
- Travel & lodging$6,30339%
- Food & beverage$9,97661%
- Education$190%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 38 | $3,600 |
| Penumbra, Inc. | 7 | $2,477 |
| Boston Scientific | 13 | $2,239 |
| Medtronic(2 entities) | 9 | $1,105 |
| Inari Medical, Inc. | 11 | $1,077 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 19 | $762 |
| Shockwave Medical, Inc | 5 | $700 |
| Amgen | 12 | $654 |
| Abiomed | 1 | $620 |
| E.r. Squibb & Sons, L.L.C. | 9 | $421 |
| Merck | 12 | $371 |
| Boehringer Ingelheim | 9 | $253 |
| Novartis | 14 | $251 |
| Cardiovascular Systems Inc. | 7 | $244 |
| Preventice Services, LLC | 2 | $167 |
| Surmodics, Inc. | 1 | $163 |
| Actelion Pharmaceuticals US, Inc. | 2 | $138 |
| Johnson & Johnson | 3 | $136 |
| Philips North America LLC | 2 | $127 |
| Cardiva Medical, Inc. | 2 | $118 |
| Imperative Care, Inc | 3 | $106 |
| Stryker | 4 | $101 |
| Cordis US CORP. | 5 | $91 |
| Alnylam Pharmaceuticals Inc. | 4 | $70 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $66 |
| Kestra Medical Technology Services, Inc. | 2 | $53 |
| Pfizer | 2 | $44 |
| Tactile Systems Technology Inc | 2 | $40 |
| AstraZeneca | 2 | $31 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $25 |
| Chiesi USA, Inc. | 1 | $20 |
| Novo Nordisk | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$2,278
- WATCHMAN Access System$1,626
- OPTIS$1,539
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$700
- Impella$620
- VenaSeal$597
- FlowTriever$539
- ClotTriever$539
- Repatha$508
- AMPLATZER Occluders$473
- FLOWTRIEVER CATHETER, S$354
- CT THROMBECTOMY SYSTEM KIT$354
- VERQUVO$238
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$181
- PRESSUREWIRE$177
- HeartMate 3 Left Ventricular Dev$164
- Sublime 014 Rx PTA Balloon Dilatation Catheter$163
- Sublime Microcatheter, 018, 200cm, Straight$163
- Pounce Thrombectomy System$163
- Pounce Thrombectomy$163
How this compares
$16,298 in reported general payments places this provider in the 80th percentile of 760 cardiovascular disease providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 257 | $325,312 |
| EntrestoSacubitril/Valsartan | 78 | $90,474 |
| JardianceEmpagliflozin | 48 | $55,385 |
| XareltoRivaroxaban | 36 | $47,823 |
| BrilintaTicagrelor | 38 | $25,403 |
| Repatha SureclickEvolocumab | 35 | $20,050 |
| FarxigaDapagliflozin Propanediol | 18 | $13,985 |
| Atorvastatin Calcium | 343 | $5,315 |
| Losartan Potassium | 406 | $4,922 |
| Metoprolol Succinate | 251 | $4,675 |
| Carvedilol | 331 | $4,002 |
| Amiodarone Hcl | 87 | $3,950 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 209 | $3,167 |
| Nifedipine ErNifedipine | 63 | $2,241 |
| ClopidogrelClopidogrel Bisulfate | 85 | $1,691 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $44 | $325,312257 claims |
| NovartisEntresto | $251 | $90,47478 claims |
| Boehringer IngelheimJardiance | $253 | $55,38548 claims |
| Johnson & JohnsonXarelto | $136 | $47,82336 claims |
| AstraZenecaBrilinta, Farxiga | $31 | $39,38756 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 760 cardiovascular disease providers in Michigan.
Other cardiovascular disease in Saint Clair Shores
- Marschall RungeAnn Arbor$1.8M
- Jihad MustaphaGrand Rapids$1.6M
- Vallerie McLaughlinAnn Arbor$947K
- Pedro Villablanca SpinettoDetroit$620K
- Stanley ChetcutiAnn Arbor$573K
- David HainesRoyal Oak$492K
- Steven AlmanyTroy$471K
- David StroblLansing$445K
- Herman KadoSouthfield$442K
- Douglas HorstmanshofRoyal Oak$407K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.